Post Conference Highlights: Reuters Events Pharma USA 2024

Share this

Post Conference Highlights: Reuters Events Pharma USA 2024


Inspiring, innovating, and trailing, the Pharma USA 2024 by Reuters Events witnessed an exceptional and exemplary gathering from the biopharmaceutical, healthcare, and tech companies. The two-day event remained the talk of the town in the healthcare fraternity, and your favorite media house PharmaShots, as a media partner was there in person to provide a panoptic and sweeping coverage of the conference. 

In a glimpse of the Pharma USA 2024 Reuters Events, you will get a condensed recapitulation of the two-day event. With thought leaders and HCPs from across the globe, Day 1 at Pharma USA 2024 revolved mostly around the company’s commercial journey powered by data and AI, medical affairs, patient engagement, accessibility, cell and gene therapy, and interactive roundtables.  

While interactive workshops at the events were the center of attraction, the lunch & networking breaks were enough for Pharma enthusiasts like us to spark a conversation with keynote speakers. 

Day 1 was pretty much a healthy blend of insights into commercialization, marketing, patient collaborations, and engagements, and finally the innovative cell and gene therapy. 

On a joyful note, we entered Day 2, which to our surprise turned out to be one of the most gripping days of our conference coverage. Delving deep into topics such as Health Equity, RWE, and medical affairs, while addressing the themes of Day 1, PharmaShots was fuelled with the energy of the speakers who articulately addressed the healthcare challenges and the solutions to bridge those gaps with technology.  

Diving deep with their insights on commercialization, speakers from IPSEN, Novartis, AstraZeneca, and Abbott kept audiences hooked throughout their presentations. When it came to marketing, we had speakers from Novartis, Pfizer, Gilead, and Organon. 

Speaking of Medical Affairs, we had keynote speakers from AstraZeneca, J&J Innovative Medicine, Genentech, BMS, and Sanofi. To share insights from patient engagement, speakers from Tigerlily Foundation, Pfizer, Genentech, Santen, and Biogen took over the podium. 

Moving ahead to Market Access & RWE, we had speakers from AbbVie, Novartis, Eisai, J&J Innovative Medicine & Roche. Diving deep insights on Cell & Gene Therapy, we had notable speakers from Blue Cross Blue Shield, Spark Therapeutics, Pfizer, CSL Behring, and FDA. 

Book your slot for the Pharma 2024 EU Barcelona Event at a discounted price with PharmaShots! 

Reach out to us at connect@pharmashots.com 

Related Post: Reuters Events: Pharma USA 2024 

Himanshu Sehgal

Himanshu brings over 12 years of Pharma, Life Sciences, and Biotech expertise to Pharmashots. A self-proclaimed "Pharma Geek," his passion for the industry shines through. His career path blends hands-on lab research with high-level consulting at firms like PwC-Health Industries and Novartis. Himanshu holds a degree in Immunology from the University of Leeds, and boasts further credentials from IIM Lucknow and the London School of Economics. Connect with Himanshu to dive deeper into the dynamic world of pharmaceuticals and life sciences.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions